{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Comparative molecular docking", "In silico analysis", "Medicinal plants", "Rheumatoid arthritis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28472734", "DateCompleted": {"Year": "2018", "Month": "03", "Day": "21"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "05"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "04", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jmgm.2017.04.013", "S1093-3263(17)30273-5"], "Journal": {"ISSN": "1873-4243", "JournalIssue": {"Volume": "74", "PubDate": {"Year": "2017", "Month": "Jun"}}, "Title": "Journal of molecular graphics & modelling", "ISOAbbreviation": "J Mol Graph Model"}, "ArticleTitle": "Comparative in silico analyses of Cannabis sativa, Prunella vulgaris and Withania somnifera compounds elucidating the medicinal properties against rheumatoid arthritis.", "Pagination": {"StartPage": "296", "EndPage": "304", "MedlinePgn": "296-304"}, "Abstract": {"AbstractText": ["From last decade, there has been progressive improvement in computational drug designing. Several diseases are being cured from different plant extracts and products. Rheumatoid Arthritis (RA) is the most shared disease among auto-inflammatory diseases. Tumour necrosis factor (TNF)-\u03b1 is associated with RA pathway and has adverse effects. Extensive literature review showed that plant species under study (Cannabis sativa, Prunella vulgaris and Withania somnifera) possess anti-inflammatory, anti-arthritic and anti-rheumatic properties. 13 anti-inflammatory compounds were characterised and filtered out from medicinal plant species and analysed for RA by targeting TNF-\u03b1 through in silico analyses. By using ligand based pharmacophore generation approach and virtual screening against natural products libraries we retrieved twenty unique molecules that displayed utmost binding affinity, least binding energies and effective drug properties. The docking analyses revealed that Ala-22, Glu-23, Ser-65, Gln-67, Tyr-141, Leu-142, Asp-143, Phe-144 and Ala-145 were critical interacting residues for receptor-ligand interactions. It is proposed that the RA patients should use reported compounds for the prescription of RA by targeting TNF-\u03b1. This report is opening new dimensions for designing innovative therapeutic targets to cure RA."], "CopyrightInformation": "Copyright \u00a9 2017 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Quaid-i-Azam University, Islamabad 45320, Pakistan."}], "LastName": "Zaka", "ForeName": "Mehreen", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biosciences, COMSATS Institute of Information Technology, Sahiwal, Pakistan; State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China; University of Chinese Academy of Sciences, Beijing, China."}], "LastName": "Sehgal", "ForeName": "Sheikh Arslan", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Centre for Bioinformatics, Quaid-i-Azam University, Islamabad 45320, Pakistan."}], "LastName": "Shafique", "ForeName": "Shagufta", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Quaid-i-Azam University, Islamabad 45320, Pakistan. Electronic address: bhabbasi@qau.edu.pk."}], "LastName": "Abbasi", "ForeName": "Bilal Haider", "Initials": "BH"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Mol Graph Model", "NlmUniqueID": "9716237", "ISSNLinking": "1093-3263"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antirheumatic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Tumor Necrosis Factor, Type I"}, {"RegistryNumber": "0", "NameOfSubstance": "TNF protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "TNFRSF1A protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Antirheumatic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Arthritis, Rheumatoid"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cannabis"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": ["chemistry"], "DescriptorName": "Prunella"}, {"QualifierName": ["chemistry"], "DescriptorName": "Receptors, Tumor Necrosis Factor, Type I"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": ["chemistry"], "DescriptorName": "Withania"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "8", "Day": "22"}, {"Year": "2017", "Month": "3", "Day": "14"}, {"Year": "2017", "Month": "4", "Day": "12"}, {"Year": "2017", "Month": "5", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "5", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28472734", "10.1016/j.jmgm.2017.04.013", "S1093-3263(17)30273-5"]}}]}